Free Trial

Abingdon Health (ABDX) Competitors

Abingdon Health logo
GBX 6.14 -0.11 (-1.71%)
As of 08:23 AM Eastern

ABDX vs. AGL, YGEN, PRM, GDR, VRCI, GENI, DMTR, LLAI, LLA, and IDHC

Should you be buying Abingdon Health stock or one of its competitors? The main competitors of Abingdon Health include ANGLE (AGL), Yourgene Health (YGEN), Proteome Sciences (PRM), genedrive (GDR), Verici Dx (VRCI), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), and Integrated Diagnostics (IDHC). These companies are all part of the "diagnostics & research" industry.

Abingdon Health vs.

ANGLE (LON:AGL) and Abingdon Health (LON:ABDX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, community ranking, risk, earnings, profitability, media sentiment and valuation.

In the previous week, ANGLE's average media sentiment score of 0.00 equaled Abingdon Health'saverage media sentiment score.

Company Overall Sentiment
ANGLE Neutral
Abingdon Health Neutral

Abingdon Health has a net margin of -20.72% compared to ANGLE's net margin of -890.91%. Abingdon Health's return on equity of -62.56% beat ANGLE's return on equity.

Company Net Margins Return on Equity Return on Assets
ANGLE-890.91% -76.01% -29.89%
Abingdon Health -20.72%-62.56%-17.93%

ANGLE has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500. Comparatively, Abingdon Health has a beta of 0.13, indicating that its share price is 87% less volatile than the S&P 500.

ANGLE received 183 more outperform votes than Abingdon Health when rated by MarketBeat users.

CompanyUnderperformOutperform
ANGLEOutperform Votes
183
62.46%
Underperform Votes
110
37.54%
Abingdon HealthN/AN/A

Abingdon Health has higher revenue and earnings than ANGLE. Abingdon Health is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ANGLE£2.44M13.52-£21.76M-£6.76-1.52
Abingdon Health£3.84M3.09-£796.37K-£0.41-14.94

18.8% of ANGLE shares are held by institutional investors. Comparatively, 33.5% of Abingdon Health shares are held by institutional investors. 16.2% of ANGLE shares are held by insiders. Comparatively, 48.9% of Abingdon Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

ANGLE presently has a consensus price target of GBX 40, indicating a potential upside of 290.24%. Given ANGLE's stronger consensus rating and higher possible upside, research analysts clearly believe ANGLE is more favorable than Abingdon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ANGLE
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Abingdon Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Abingdon Health beats ANGLE on 8 of the 15 factors compared between the two stocks.

Get Abingdon Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABDX vs. The Competition

MetricAbingdon HealthDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£11.90M£786.60M£5.33B£2.66B
Dividend YieldN/A5.44%5.21%5.05%
P/E Ratio-14.942.0826.71129.21
Price / Sales3.09543.73386.12221,406.01
Price / Cash2.2511.4238.2528.02
Price / Book8.442.516.773.79
Net Income-£796,369.64£286.34B£3.23B£5.88B
7 Day Performance-3.46%5.02%1.80%0.63%
1 Month Performance3.24%2.57%11.10%22.11%
1 Year Performance-42.56%-10.28%17.11%120.87%

Abingdon Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABDX
Abingdon Health
N/AGBX 6.14
-1.7%
N/A-42.9%£11.90M£3.84M-14.9484Gap Down
High Trading Volume
AGL
ANGLE
1.2738 of 5 stars
GBX 8
-6.3%
GBX 40
+400.0%
-53.7%£25.78M£2.44M-1.18650
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
PRM
Proteome Sciences
N/AGBX 3.90
+19.6%
N/A-2.2%£11.51M£10.88B-2.82240Gap Up
High Trading Volume
GDR
genedrive
N/AGBX 1.36
-0.7%
N/A-18.7%£7.69M£1.50M-0.3843High Trading Volume
VRCI
Verici Dx
N/AGBX 1.17
-15.1%
N/A-85.1%£3.55M£5.91M-0.6819Gap Down
GENI
GENinCode
N/AGBX 1.50
-6.3%
N/A-80.9%£2.66M£2.67M-0.442,300News Coverage
Gap Up
High Trading Volume
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 3.75
+7.1%
N/A-82.9%£1.24M£33,871.03-0.3015Gap Down
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-8.3315Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.36
+2.9%
N/A+14.3%£10.60B£23.29T13.386,692

Related Companies and Tools


This page (LON:ABDX) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners